Interaction/NN
between/IN
NF-kappa/NN
B-/NN
and/CC
serum/NN
response/NN
factor-binding/JJ
elements/NNS
activates/VBZ
an/DT
interleukin-2/NN
receptor/NN
alpha-chain/JJ
enhancer/NN
specifically/RB
in/IN
T/NN
lymphocytes/NNS
./.

We/PRP
find/VBP
that/IN
a/DT
short/JJ
enhancer/NN
element/NN
containing/VBG
the/DT
NF-kappa/NN
B/NN
binding/NN
site/NN
from/IN
the/DT
interleukin-2/NN
receptor/NN
alpha-chain/JJ
gene/NN
(/(
IL-2R/NN
alpha/NN
)/)
is/VBZ
preferentially/RB
activated/VBN
in/IN
T/NN
cells/NNS
./.
=====
The/DT
IL-2R/NN
alpha/NN
enhancer/NN
binds/VBZ
NF-kappa/NN
B/NN
poorly/RB
and/CC
is/VBZ
only/RB
weakly/RB
activated/VBN
by/IN
the/DT
NF-kappa/NN
B/NN
site/NN
alone/RB
./.
=====
Serum/NN
response/NN
factor/NN
(/(
SRF/NN
)/)
binds/VBZ
to/TO
a/DT
site/NN
adjacent/JJ
to/TO
the/DT
NF-kappa/NN
B/NN
site/NN
in/IN
the/DT
IL-2R/NN
enhancer/NN
,/,
and/CC
both/DT
sites/NNS
together/RB
have/VBP
strong/JJ
transcriptional/JJ
activity/NN
specifically/RB
in/IN
T/NN
cells/NNS
./.
=====
Surprisingly/RB
,/,
the/DT
levels/NNS
of/IN
SRF/NN
constitutively/RB
expressed/VBN
in/IN
T/NN
cells/NNS
are/VBP
consistently/RB
higher/JJR
than/IN
in/IN
other/JJ
cell/NN
types/NNS
./.
=====
Overexpression/NN
of/IN
SRF/NN
in/IN
B/NN
cells/NNS
causes/VBZ
the/DT
IL-2R/NN
enhancer/NN
to/TO
function/VB
as/RB
well/RB
as/IN
it/PRP
does/VBZ
in/IN
T/NN
cells/NNS
,/,
suggesting/VBG
that/IN
the/DT
high/JJ
level/NN
of/IN
SRF/NN
binding/NN
in/IN
T/NN
cells/NNS
is/VBZ
functionally/RB
important/JJ
./.